Proteomics profiling reveals a distinct high-risk molecular subtype of hypertrophic cardiomyopathy.

MLA

Liang, Lusha W., et al. “Proteomics Profiling Reveals a Distinct High-Risk Molecular Subtype of Hypertrophic Cardiomyopathy.” Heart (British Cardiac Society), vol. 108, no. 22, Oct. 2022, pp. 1807–14. EBSCOhost, https://doi.org/10.1136/heartjnl-2021-320729.

APA

Liang, L. W., Raita, Y., Hasegawa, K., Fifer, M. A., Maurer, M. S., Reilly, M. P., & Shimada, Y. J. (2022). Proteomics profiling reveals a distinct high-risk molecular subtype of hypertrophic cardiomyopathy. Heart (British Cardiac Society), 108(22), 1807–1814. https://doi.org/10.1136/heartjnl-2021-320729

Chicago

Liang, Lusha W, Yoshihiko Raita, Kohei Hasegawa, Michael A Fifer, Mathew S Maurer, Muredach P Reilly, and Yuichi J Shimada. 2022. “Proteomics Profiling Reveals a Distinct High-Risk Molecular Subtype of Hypertrophic Cardiomyopathy.” Heart (British Cardiac Society) 108 (22): 1807–14. doi:10.1136/heartjnl-2021-320729.